A novel computational approach for drug repurposing using systems biology.

Area of Science:

• Computational biology and bioinformatics
• Systems biology
• Drug discovery and development

Background:

• Drug repurposing accelerates the discovery of new therapeutic effects for existing drugs.
• Current computational methods often rely on gene expression signatures, which may overlook system-level gene interactions.
• Existing approaches may not fully capture the complexity of drug-disease relationships.

Purpose of the Study:

• To propose a novel systems biology approach for identifying new therapeutic applications of established drugs.
• To address limitations of current transcriptional data-based drug repurposing methods.
• To leverage network-based analysis for more accurate drug-disease association.

Main Methods:

• Constructed a comprehensive drug-disease network integrating drug targets, disease genes, and signaling pathways.
• Incorporated gene-expression data for system-level analysis.
• Compared the proposed network-based approach with a transcriptional signature-based method (Sirota et al.) for four diseases.

Main Results:

• The systems biology approach identified novel therapeutic roles for existing drugs.
• The method demonstrated effectiveness in re-discovering FDA-approved drugs for specific diseases.
• The proposed approach offers a more holistic analysis compared to signature-matching methods.

Conclusions:

• A systems biology approach provides a powerful framework for drug repurposing.
• Network integration and system-level analysis enhance the accuracy of predicting therapeutic effects.
• The developed R package, DrugDiseaseNet, facilitates this novel drug repurposing strategy.